We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current KTTA market cap is 7.43M. The company's latest EPS is USD -15.3211 and P/E is -0.47.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Revenue | 219k | 241k | 0 | 0 | 0 |
| Operating Income | -4.25M | -5.08M | -3.21M | -3.83M | -3.79M |
| Net Income | -4.59M | -5.12M | -3.54M | -3.76M | -3.61M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 15k | 487k | 0 |
| Operating Income | -41k | -4.51M | -14.82M | -15.98M |
| Net Income | -41k | -2.17M | -13.94M | -15.96M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Assets | 49.61M | 45.18M | 42.05M | 38.15M | 30.66M |
| Total Liabilities | 2.82M | 2.68M | 2.91M | 2.56M | 2.28M |
| Total Equity | 46.79M | 42.5M | 39.14M | 35.59M | 28.37M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 248k | 53.32M | 45.18M | 26.12M |
| Total Liabilities | 7k | 1.9M | 2.68M | 2.72M |
| Total Equity | 241k | 51.42M | 42.5M | 23.4M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Operating | -10.14M | -14.56M | -3.39M | -6.87M | -10.11M |
| Investing | -305k | -2.06M | -50k | 295k | 344k |
| Financing | N/A | -3.21M | 264k | 133k | -3.73M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -38k | -3.17M | -14.56M | -13.43M |
| Investing | N/A | -22k | -2.06M | 398k |
| Financing | 282k | 55.93M | -3.21M | -3.73M |
| Market Cap | 7.43M |
| Price to Earnings Ratio | -0.47 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.45 |
| Price to Book Ratio | 0.32 |
| Dividend Yield | - |
| Shares Outstanding | 1.04M |
| Average Volume (1 week) | 485 |
| Average Volume (1 Month) | 1.05k |
| 52 Week Change | 11.41% |
| 52 Week High | 17.40 |
| 52 Week Low | 5.254 |
| Spread (Intraday) | 1.56 (20.39%) |
| Company Name | Pasithea Therapeutics Corporation |
| Address |
8 the green ste a dover, delaware 19901 |
| Website | https://www.pasithea.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
